Tumors of female reproductive systemTumors of female reproductive systemОпухоли женской репродуктивной системы1994-40981999-8627Publishing House ABV Press1710.17650/1994-4098-2014-0-1-81-84GYNECOLOGY. TREATMENTГИНЕКОЛОГИЯ. ЛЕЧЕНИЕImpact of hyperbaric oxygenation on the efficiency of combined treatment for ovarian cancerВлияние гипербарической оксигенации на эффективность комбинированного лечения рака яичниковDzasokhovA. S.ДзасоховА. С.
Russian Federation
apprentice@list.ruMoscow Regional Oncology Dispensary, BalashikhaГБУЗ МО «Московский областной онкологический диспансер», Балашиха17072014181841707201417072014https://ojrs.abvpress.ru/ojrs/article/view/17

The author’s findings suggest the higher efficiency of standard combined treatment for ovarian cancer in combination with chemotherapy and oxygen therapy.

Полученные автором данные свидетельствуют о повышении эффективности стандартного комбинированного лечения рака яичников при сочетании химио- и оксигенотерапии.

ovarian cancerchemotherapyoxygen therapyhyperbaric oxygenationрак яичниковхимиотерапияоксигенотерапиягипербарическая оксигенация1. Аксель Е.М. Статистика злокачественных новообразований женской половой сферы. Онкогинекология 2012;(1):18–23.Аксель Е.М. Статистика злокачественных новообразований женской половой сферы. Онкогинекология 2012;(1):18–23.2. Тюляндин С.А., Носов Д.А., Переводчикова Н.И. Минимальные клинические рекомендации Европейского Общества Медицинской Онкологии (ESMO). М.: Издательская группа РОНЦТюляндин С.А., Носов Д.А., Переводчикова Н.И. Минимальные клинические рекомендации Европейского Общества Медицинской Онкологии (ESMO). М.: Издательская группа РОНЦим. Н.Н. Блохина, редакция русского перевода, 2010. 436 с.3. Awada A., Klastersky J. Ovarian cancer: state of the art and future directions. Eur J Gynaecol Oncol 2004;25(6):673–6.Awada A., Klastersky J. Ovarian cancer: state of the art and future directions. Eur J Gynaecol Oncol 2004;25(6):673–6.4. Dhillon P.K., Yeole B.B., Dikshit R. et al. Trends in breast, ovarian and cervical cancer incidence in Mumbai, India over a 30-year period, 1976–2005: an age-period-cohort analysis. Br J Cancer 2011;105(5):723–30. 5. World Health Organization. World health statistics. WHO Library Cataloguing-in- Publication Data, 2012. P. 43–79.Dhillon P.K., Yeole B.B., Dikshit R. et al. Trends in breast, ovarian and cervical cancer incidence in Mumbai, India over a 30-year period, 1976–2005: an age-period-cohort analysis. Br J Cancer 2011;105(5):723–30. 5. World Health Organization. World health statistics. WHO Library Cataloguing-in- Publication Data, 2012. P. 43–79.6. Ivanov S., Ivanov S., Khadzhiolov N. Prognostic factors and better survival rate after the treatment of advanced ovarian cancer with neoadjuvant chemotherapy. Akush Ginekol (Sofiia) 2004;43(6):17–9.Ivanov S., Ivanov S., Khadzhiolov N. Prognostic factors and better survival rate after the treatment of advanced ovarian cancer with neoadjuvant chemotherapy. Akush Ginekol (Sofiia) 2004;43(6):17–9.7. Rose P.G. Which is the best foot to put forward in recurrent ovarian cancer? Cancer 2012;118(13):3229–31.Rose P.G. Which is the best foot to put forward in recurrent ovarian cancer? Cancer 2012;118(13):3229–31.8. Alagoz T., Buller R.E., Anderson B. et al. Evaluation of hyperbaric oxygen as a chemosensitizer in the treatment of epithelial ovarian cancer in xenografts in mice. Cancer 1995;75(9):2313–22.Alagoz T., Buller R.E., Anderson B. et al. Evaluation of hyperbaric oxygen as a chemosensitizer in the treatment of epithelial ovarian cancer in xenografts in mice. Cancer 1995;75(9):2313–22.9. Mueller-Klieser W., Schaefer C., Walenta S. et al. Assessment of tumor energy and oxygenation status by bioluminescence, nuclear magnetic resonance spectroscopy, and cryospectrophotometry. Cancer Res 1990;50(6):1681–5.Mueller-Klieser W., Schaefer C., Walenta S. et al. Assessment of tumor energy and oxygenation status by bioluminescence, nuclear magnetic resonance spectroscopy, and cryospectrophotometry. Cancer Res 1990;50(6):1681–5.10. Vaupel P., Höckel M. Tumor oxygenation and its relevance to tumor physiology and treatment. Adv Exp Med Biol 2003;510:45–9. 11. Weinmann M., Belka C., Plasswilm L. Tumour hypoxia: impact on biology, prognosis and treatment of solid malignant tumours. Onkologie 2004;27(1):83–90.Vaupel P., Höckel M. Tumor oxygenation and its relevance to tumor physiology and treatment. Adv Exp Med Biol 2003;510:45–9. 11. Weinmann M., Belka C., Plasswilm L. Tumour hypoxia: impact on biology, prognosis and treatment of solid malignant tumours. Onkologie 2004;27(1):83–90.12. Cassileth B. Oxygen therapies. Oncology (Williston Park) 2009;23(13):1182.Cassileth B. Oxygen therapies. Oncology (Williston Park) 2009;23(13):1182.13. ДзасоховА.С.Патогенетическое обоснование применения оксигенотерапии в онкологии. ВНМТ 2011;8(4):196.ДзасоховА.С.Патогенетическое обоснование применения оксигенотерапии в онкологии. ВНМТ 2011;8(4):196.14. Dar'ialovaS.L.,VedernikovaN.V.,BergutF.L., Zel'vin BM. Use of antitumor preparations under hyperbaric oxygenation in ovarian cancer. Akush Ginekol (Mosk) 1979;(12):34–6.Dar'ialovaS.L.,VedernikovaN.V.,BergutF.L., Zel'vin BM. Use of antitumor preparations under hyperbaric oxygenation in ovarian cancer. Akush Ginekol (Mosk) 1979;(12):34–6.15. RusyniakD.E.,KirkM.A.,MayJ.D.etal. Hyperbaric oxygen therapy in acute ischemic stroke: results of the Hyperbaric Oxygen in Acute Ischemic Stroke Trial Pilot Study. Stroke 2003;34(2):571–4.RusyniakD.E.,KirkM.A.,MayJ.D.etal. Hyperbaric oxygen therapy in acute ischemic stroke: results of the Hyperbaric Oxygen in Acute Ischemic Stroke Trial Pilot Study. Stroke 2003;34(2):571–4.16. Moen I., Stuhr L.E. Hyperbaric oxygen therapy and cancer – a review. Target Oncol 2012;7(4):233–42.Moen I., Stuhr L.E. Hyperbaric oxygen therapy and cancer – a review. Target Oncol 2012;7(4):233–42.17. Guyot P., Ades A.E., Ouwens M.J., Welton N.J. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol 2012;12:9.Guyot P., Ades A.E., Ouwens M.J., Welton N.J. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol 2012;12:9.